Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,784 | N/A | -7,822 | -4,775 | 8,550 |
| Depreciation Amortization | 3 | N/A | 3 | N/A | 5,760 |
| Accounts payable and accrued liabilities | -2,915 | N/A | 1,958 | 271 | N/A |
| Other Working Capital | -4,109 | N/A | 2,415 | -721 | 30,650 |
| Other Operating Activity | 1,838 | 0 | -339 | 1,017 | 3,270 |
| Operating Cash Flow | $-10,967 | $N/A | $-3,786 | $-4,207 | $48,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -187 | N/A | -6,091 | N/A | -9,350 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3,260 |
| Investing Cash Flow | $-187 | $N/A | $-6,091 | $N/A | $-12,610 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 3,545 | N/A | N/A |
| Common Stock Issued | 20,450 | N/A | 25,426 | 11,254 | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -6,450 |
| Other Financing Activity | 0 | 0 | -325 | 0 | -27,860 |
| Financing Cash Flow | $20,450 | $N/A | $28,647 | $11,254 | $-34,310 |
| Beginning Cash Position | 10,547 | N/A | N/A | N/A | 800 |
| End Cash Position | 19,843 | N/A | 18,770 | 7,046 | 2,100 |
| Net Cash Flow | $9,296 | $N/A | $18,770 | $7,046 | $1,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,967 | N/A | -3,786 | -4,207 | 48,230 |
| Capital Expenditure | -187 | N/A | -6,091 | N/A | N/A |
| Free Cash Flow | -11,154 | 0 | -9,877 | -4,207 | 48,230 |